Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults

IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
Pek Kei Im , Christiana Kartsonaki , Maria G. Kakkoura , Olaa Mohamed-Ahmed , Ling Yang , Yiping Chen , Huaidong Du , Xiaoming Yang , Hua Zhang , Dianjianyi Sun , Canqing Yu , Jun Lv , Liming Li , Zhengming Chen , Iona Y. Millwood
{"title":"Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults","authors":"Pek Kei Im ,&nbsp;Christiana Kartsonaki ,&nbsp;Maria G. Kakkoura ,&nbsp;Olaa Mohamed-Ahmed ,&nbsp;Ling Yang ,&nbsp;Yiping Chen ,&nbsp;Huaidong Du ,&nbsp;Xiaoming Yang ,&nbsp;Hua Zhang ,&nbsp;Dianjianyi Sun ,&nbsp;Canqing Yu ,&nbsp;Jun Lv ,&nbsp;Liming Li ,&nbsp;Zhengming Chen ,&nbsp;Iona Y. Millwood","doi":"10.1016/j.lanwpc.2025.101572","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Despite the growing prevalence of hyperuricemia and gout, their epidemiology and associated comorbidity burden remains poorly studied in many populations, including China. We aimed to examine the patterns of plasma urate level, prevalence of hyperuricemia, and incidence of gout, and investigate the associations of gout with a range of comorbidities and all-cause mortality in Chinese adults.</div></div><div><h3>Methods</h3><div>The prospective China Kadoorie Biobank recruited 512,724 adults aged 30–79 years from ten diverse areas in 2004–2008 and measured plasma urate level among 16,817 participants. The incidence of gout and other diseases and deaths were monitored by electronic linkages with registries and hospital records. Cox and logistic regression yielded adjusted HRs and ORs for risks of mortality and comorbidities associated with gout, hyperuricemia, and urate level.</div></div><div><h3>Findings</h3><div>The gout incidence rate was 23.4 per 100,000 person-years, and was higher in men and older participants, and varied substantially by region. Gout was associated with higher risks of all-cause mortality (HR = 1.58, 95% CI 1.37–1.82), CVD (1.87, 1.64–2.14), CKD (5.61, 4.45–7.07), urolithiasis (2.50, 1.85–3.38), diabetes (1.99, 1.51–2.62), diseases of the oesophagus, stomach, and duodenum (2.14, 1.72–2.66), infectious and parasitic diseases (1.91, 1.47–2.48), arthropathies (6.06, 4.98–7.38), and other musculoskeletal disorders (2.10, 1.77–2.51). Most of these associations were bi-directional, sustained over time and little affected by adjustment for cardiometabolic risk factors. Moreover, participants who developed gout were more likely to have multiple major diseases and more hospitalisations. Among the subset with plasma urate measured, 15% had hyperuricemia, which was more common in men, older women, and urban residents, and was associated with increased risks of gout, all-cause mortality, and several cardiometabolic, renal, digestive, and musculoskeletal diseases.</div></div><div><h3>Interpretation</h3><div>In Chinese adults, gout was associated with several comorbidities and a poor health trajectory. Our findings reinforce the need for prevention and management of gout and associated comorbidities.</div></div><div><h3>Funding</h3><div><span>Kadoorie Charitable Foundation</span>, <span>National Natural Science Foundation of China</span>, <span>Noncommunicable Chronic Diseases-National Science and Technology Major Project</span>, <span>British Heart Foundation</span>, <span>Cancer Research UK</span>, <span>Wellcome Trust</span>, <span>UK Medical Research Council</span>, <span>Nuffield Department of Population Health at the University of Oxford</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"58 ","pages":"Article 101572"},"PeriodicalIF":7.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666606525001099","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Despite the growing prevalence of hyperuricemia and gout, their epidemiology and associated comorbidity burden remains poorly studied in many populations, including China. We aimed to examine the patterns of plasma urate level, prevalence of hyperuricemia, and incidence of gout, and investigate the associations of gout with a range of comorbidities and all-cause mortality in Chinese adults.

Methods

The prospective China Kadoorie Biobank recruited 512,724 adults aged 30–79 years from ten diverse areas in 2004–2008 and measured plasma urate level among 16,817 participants. The incidence of gout and other diseases and deaths were monitored by electronic linkages with registries and hospital records. Cox and logistic regression yielded adjusted HRs and ORs for risks of mortality and comorbidities associated with gout, hyperuricemia, and urate level.

Findings

The gout incidence rate was 23.4 per 100,000 person-years, and was higher in men and older participants, and varied substantially by region. Gout was associated with higher risks of all-cause mortality (HR = 1.58, 95% CI 1.37–1.82), CVD (1.87, 1.64–2.14), CKD (5.61, 4.45–7.07), urolithiasis (2.50, 1.85–3.38), diabetes (1.99, 1.51–2.62), diseases of the oesophagus, stomach, and duodenum (2.14, 1.72–2.66), infectious and parasitic diseases (1.91, 1.47–2.48), arthropathies (6.06, 4.98–7.38), and other musculoskeletal disorders (2.10, 1.77–2.51). Most of these associations were bi-directional, sustained over time and little affected by adjustment for cardiometabolic risk factors. Moreover, participants who developed gout were more likely to have multiple major diseases and more hospitalisations. Among the subset with plasma urate measured, 15% had hyperuricemia, which was more common in men, older women, and urban residents, and was associated with increased risks of gout, all-cause mortality, and several cardiometabolic, renal, digestive, and musculoskeletal diseases.

Interpretation

In Chinese adults, gout was associated with several comorbidities and a poor health trajectory. Our findings reinforce the need for prevention and management of gout and associated comorbidities.

Funding

Kadoorie Charitable Foundation, National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, British Heart Foundation, Cancer Research UK, Wellcome Trust, UK Medical Research Council, Nuffield Department of Population Health at the University of Oxford.
中国高尿酸血症、痛风及相关合并症:来自50万成年人的前瞻性研究结果
背景:尽管高尿酸血症和痛风的患病率越来越高,但在包括中国在内的许多人群中,对其流行病学和相关合并症负担的研究仍然很少。我们的目的是研究血浆尿酸水平、高尿酸血症患病率和痛风发病率的模式,并研究痛风与一系列合并症和全因死亡率的关系。方法2004-2008年,中国嘉里生物库从10个不同地区招募了512,724名年龄在30-79岁之间的成年人,并测量了16,817名参与者的血浆尿酸水平。通过与登记处和医院记录的电子联系监测痛风和其他疾病的发病率和死亡情况。Cox和logistic回归得出与痛风、高尿酸血症和尿酸水平相关的死亡风险和合并症的调整hr和or。研究结果:痛风发病率为23.4 / 100000人/年,男性和老年人的发病率更高,不同地区的发病率差异很大。痛风与全因死亡率(HR = 1.58, 95% CI 1.37-1.82)、心血管疾病(1.87,1.64-2.14)、慢性肾病(5.61,4.45-7.07)、尿石症(2.50,1.85-3.38)、糖尿病(1.99,1.51-2.62)、食道、胃和十二指肠疾病(2.14,1.72-2.66)、感染性和寄生虫病(1.91,1.47-2.48)、关节病(6.06,4.98-7.38)和其他肌肉骨骼疾病(2.10,1.77-2.51)相关。这些关联大多数是双向的,持续一段时间,很少受心脏代谢危险因素调整的影响。此外,患有痛风的参与者更有可能患有多种主要疾病,住院治疗的次数也更多。在测量血浆尿酸盐的亚组中,15%患有高尿酸血症,这在男性、老年女性和城市居民中更为常见,并与痛风、全因死亡率以及几种心脏代谢、肾脏、消化和肌肉骨骼疾病的风险增加有关。在中国成年人中,痛风与几种合并症和不良的健康轨迹有关。我们的研究结果加强了预防和管理痛风及相关合并症的必要性。资助:嘉道理慈善基金会、中国国家自然科学基金、非传染性慢性病国家科技重大专项、英国心脏基金会、英国癌症研究中心、惠康基金会、英国医学研究理事会、牛津大学纳菲尔德人口健康系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
The Lancet Regional Health: Western Pacific
The Lancet Regional Health: Western Pacific Medicine-Pediatrics, Perinatology and Child Health
CiteScore
8.80
自引率
2.80%
发文量
305
审稿时长
11 weeks
期刊介绍: The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信